Nektar Therapeutics Files 8-K with Exhibits
Ticker: NKTR · Form: 8-K · Filed: Apr 20, 2026 · CIK: 0000906709
Sentiment: neutral
Topics: filing, sec-report
Related Tickers: NKTR
TL;DR
Nektar Therapeutics filed an 8-K on 4/20/2026 with various exhibits, no major news.
AI Summary
On April 20, 2026, Nektar Therapeutics filed an 8-K report detailing events under Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The filing includes various exhibits, such as iXBRL data and graphical representations, but does not contain specific financial figures or new material events disclosed in the summary text.
Why It Matters
This filing indicates Nektar Therapeutics is providing updated information and exhibits to the SEC, which may contain details relevant to investors, though no specific new material events are summarized.
Risk Assessment
Risk Level: low — The filing is a routine 8-K with exhibits, not announcing significant new events or financial changes.
Key Players & Entities
- Nektar Therapeutics (company) — Filer of the 8-K report
- 0000906709 (company) — Filer CIK number
- 0001193125-26-162763 (other) — SEC Accession Number for the filing
- 2026-04-20 (date) — Filing Date and Period of Report
FAQ
What is the primary purpose of this 8-K filing by Nektar Therapeutics?
The 8-K filing serves as a current report, covering items such as Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits, as indicated by the filing date of April 20, 2026.
What specific financial information is disclosed in the summary of this 8-K?
The provided filing details do not include specific dollar amounts or financial figures in the summary text; it primarily lists the types of documents included as exhibits.
What are the main items covered in Nektar Therapeutics' 8-K filing dated April 20, 2026?
The filing covers Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).
What types of documents are included as exhibits in this filing?
The exhibits include an iXBRL 8-K document, and numerous graphical files (e.g., g25375ex99_2p10g1.jpg) which appear to be part of EX-99.1 and EX-99.2.
When was this 8-K filing accepted by the SEC?
The filing was accepted by the SEC on April 20, 2026, at 08:02:01.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 20, 2026 regarding NEKTAR THERAPEUTICS (NKTR).